Guanze Medical Information Industry (Holding) Co., Ltd.

As of December 31, 2024, Guanze Medical Information Industry (Holding) Co., Ltd. carries a market capitalization of 318.25M, placing it among publicly traded companies globally. Its enterprise value stands at 308.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Guanze Medical Information Industry (Holding) Co., Ltd. has 950.00M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Guanze Medical Information Industry (Holding) Co., Ltd. maintains a current ratio of 5.64, meaning it holds 5.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Guanze Medical Information Industry (Holding) Co., Ltd.'s stock has gained approximately 441.35% over the past 52 weeks. The 50-day moving average sits at 2.53, while the 200-day moving average is 2.98.

As of December 31, 2024, Guanze Medical Information Industry (Holding) Co., Ltd. holds 30.04M in cash and equivalents against 19.31M in total debt, resulting in a net debt position of -11.19M. Total book value stands at 276.00M, with working capital of 214.95M providing operational flexibility.